Clinical Trial Update: Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial [Phase 1, Phase 2]

View source ↗

Summary

A Phase I–II trial evaluating a four-drug combination of vinorelbine, paclitaxel, trastuzumab, and filgrastim for stage IV breast cancer; the study was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Navelbine (vinorelbine)
• Neupogen (Filgrastim)
• Taxol (paclitaxel)

Snippet

Sponsor: University of Washington | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-06-06